Homo sapiens Protein: FBLN5 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-16579.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | FBLN5 | ||||||||||||||||||
Protein Name | fibulin 5 | ||||||||||||||||||
Synonyms | ADCL2; ARCL1A; ARMD3; DANCE; EVEC; FIBL-5; UP50; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000345008 | ||||||||||||||||||
InnateDB Gene | IDBG-16575 (FBLN5) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Could be a vascular ligand for integrin receptors and may play a role in vascular development and remodeling. | ||||||||||||||||||
Subcellular Localization | Secreted. | ||||||||||||||||||
Disease Associations | Cutis laxa, autosomal dominant, 2 (ADCL2) [MIM:614434]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema. {ECO:0000269PubMed:12618961}. Note=The disease is caused by mutations affecting the gene represented in this entry.Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. The clinical spectrum of autosomal recessive cutis laxa is highly heterogeneous with respect to organ involvement and severity. Type I autosomal recessive cutis laxa is a specific, life-threatening disorder with organ involvement, lung atelectasis and emphysema, diverticula of the gastrointestinal and genitourinary systems, and vascular anomalies. Associated cranial anomalies, late closure of the fontanel, joint laxity, hip dislocation, and inguinal hernia have been observed but are uncommon. {ECO:0000269PubMed:12189163, ECO:0000269PubMed:16691202}. Note=The disease is caused by mutations affecting the gene represented in this entry.Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269PubMed:15269314}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Expressed predominantly in heart, ovary, and colon but also in kidney, pancreas, testis, lung and placenta. Not detectable in brain, liver, thymus, prostate, or peripheral blood leukocytes. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 12 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000742
Epidermal growth factor-like domain IPR001881 EGF-like calcium-binding domain IPR002919 Trypsin Inhibitor-like, cysteine rich domain |
||||||||||||||||||
PFAM |
PF00008
PF07645 PF01826 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00181
SM00179 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | Q9UBX5 | ||||||||||||||||||
PhosphoSite | PhosphoSite-Q9UBX5 | ||||||||||||||||||
TrEMBL | G3V3Y2 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 10516 | ||||||||||||||||||
UniGene | Hs.707292 | ||||||||||||||||||
RefSeq | NP_006320 | ||||||||||||||||||
HUGO | HGNC:3602 | ||||||||||||||||||
OMIM | 604580 | ||||||||||||||||||
CCDS | CCDS9898 | ||||||||||||||||||
HPRD | 05204 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AF093118 AF112152 AJ133490 AK075147 AL049872 AL590328 AY358898 BC022280 CH471061 CR457140 | ||||||||||||||||||
GenPept | AAC62107 AAD41768 AAH22280 AAQ89257 BAG52073 CAB38568 CAG33421 EAW81466 EAW81467 | ||||||||||||||||||